Table 1.
Variable | Control | Risperidone |
---|---|---|
RWAT | ||
Adipocyte diameter | ||
0–50 μm (%) | 21.67 ± 2.90 | 12.67 ± 2.88 *** |
50–100 μm (%) | 48.33 ± 3.85 | 27.67 ± 3.57 *** |
100–150 μm (%) | 28.33 ± 2.18 | 42.99 ± 3.22 *** |
>150 μm (%) | 1.67 ± 0.25 | 16.67 ± 3.05 *** |
EWAT | ||
Adipocyte diameter | ||
0–50 μm (%) | 8.33 ± 1.48 | 0 ± 0 *** |
50–100 μm (%) | 30.01 ± 2.97 | 3.33 ± 0.37 *** |
100–150 μm (%) | 33.33 ± 3.25 | 40.00 ± 3.57 ** |
>150 μm (%) | 28.33 ± 2.59 | 56.67 ± 4.94 *** |
All data for both groups are presented as means ± standard deviation. *** p < 0.001. n = 10 for both groups.